covid19.figshare.com
      updated 7 april 2020 at 01:08 GMT
Submit or suggest more data

Treatments studied

Findings listed here should only be used for research purposes. No individual should interpret these findings for any self-diagnosis or self-medication without the prior approval from competent international health/medical regulatory agencies.

Substances / Treatments
Proportion

Remdesivir

Darunavir

Chloroquine

Lopinavir

Interferon

74.9%

70.6%

1.1%

8.2%

-

Breakdown from sources

Remdesivir

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Brandi Williamson Friederike Feldmann Benjamin Schwarz Kimberly Meade-White Danielle Porter Jonathan Schulz Neeltje van Doremalen Ian Leighton Claude Kwe Yinda Lizzette Perez-Perez Atsushi Okumura Jamie Lovaglio Patrick Hanley Greg Saturday Catharine Bosio Sarah Anzick Kent Barbian Tomas Cihlar Craig Martens Dana Scott Vincent J. Munster Emmie de Wit

Dataset
 listed on 
14.4.2020

nelfinavir

pitavastatin

perampanel

praziquantel

The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future

Jin-Yan Li, Zhi You, Qiong Wang, Zhi-Jian Zhou, Ye Qiu, Rui Luo, Xing-Yi Gea

Article
 listed on 
7.4.2020

indinavir

Discovery of New Hydroxyethylamine Analogs Against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation and Structure-Activity Relationship Studies

Sumit Kumar Prem Prakash Sharma Uma Shankar Dhruv Kumar Sanjeev K Joshi Lindomar Pena Ravi Durvasula Amit Kumar Prakasha Kempaiah Poonam . Brijesh Rathi

Preprint
 listed on 
7.4.2020

convalescent plasma transfusion

The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study

Kai Duan, Bende Liu, Cesheng Li, Huajun Zhang, Ting Yu, Jieming Qu, Min Zhou, Li Chen, Shengli Meng, Yong Hu, Cheng Peng, Mingchao Yuan, Jinyan Huang, Zejun Wang, Jianhong Yu, Xiaoxiao Gao, Dan Wang, Xiaoqi Yu, Li Li, Jiayou Zhang, Xiao Wu, Bei Li, Yanping Yu, Wei Chen, Yan Peng, Yeqin Hu, Lianzhen Lin, Xuefei Liu, Shihe Huang, Zhijun Zhou, Lianghao Zhang, Yue Wang, Zhi Zhang, Kun Deng, Zhiwu Xia, Qin Gong, Wei Zhang, Xiaobei Zheng, Ying Liu, Huichuan Yang, Dongbo Zhou, Ding Yu, Jifeng Hou, Zhengli Shi, Saijuan Chen, Zhu Chen, Xin-xin Zhang, Xiaoming Yang

Preprint
 listed on 
7.4.2020

single-domain camelid antibodies

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Wander Van Breedam, Kenny Roose, Loes van Schie, Markus Hoffmann, Stefan Pöhlmann, Barney S. Graham, Nico Callewaert, Bert Schepens, Xavier Saelens, Jason S. McLellan

Preprint
 listed on 
7.4.2020

Hydoxychloroquin

Azithromycin

covid 19.pdf

Herbert Allen

Journal Contribution
 listed on 
6.4.2020

lopinavir/ritonavir

arbidol

chloroquine

Interferon

Darunavir/cobicistat

Manual de Prevenção e Tratamento da COVID-19 - Handbook of Prevention and Treatment of COVID-19

Joana Sofia Casimiro de Andrade, David Andrade

Book
 listed on 
6.4.2020

Chloroquine

Lopinavir

Chloroquine and Lopinavir (COVID-19 Drug Candidates) Signal Amplification by Reversible Exchange

HyeJin Jeong Sein Min Heelim Chae Sara Kim Gunwoo Lee Sung Keon Namgoong Keunhong Jeong

Preprint
 listed on 
6.4.2020

Other related sources

COVID-19 vaccine candidates: Prediction and validation of 174 novel SARS-CoV-2 epitopes
Marek Prachar, Sune Justesen, Daniel Bisgaard Steen-Jensen, Stephan Thorgrimsen, Erik Jurgons, Ole Winther, Frederik Otzen Bagger
listed on:
March 30, 2020